Citius Pharmaceuticals, Inc.

NASDAQ:CTXR

1.47 (USD) • At close July 29, 2025
Bedrijfsnaam Citius Pharmaceuticals, Inc.
Symbool CTXR
Munteenheid USD
Prijs 1.47
Beurswaarde 16,426,515
Dividendpercentage 0%
52-weken bereik 0.65 - 26.25
Industrie Biotechnology
Sector Healthcare
CEO Mr. Leonard L. Mazur
Website https://www.citiuspharma.com

An error occurred while fetching data.

Over Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related

Vergelijkbare Aandelen

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

0.54 USD

DarioHealth Corp. logo

DarioHealth Corp.

DRIO

0.545 USD

Assertio Holdings, Inc. logo

Assertio Holdings, Inc.

ASRT

0.711 USD

IO Biotech, Inc. logo

IO Biotech, Inc.

IOBT

2.19 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

17.16 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

0.82 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)